News - Grup de recerca CHEMINFORMATICS-NUTRITION

A new article about The Mutational Landscape of SARS-CoV-2.

Wed, 11 Oct 2023 08:24:28 +0000

A new PhD Thesis

Wed, 17 May 2023 08:26:02 +0000

Guillem Macip Sancho defended his PhD thesis entitled “Studying the limits of protein-ligand docking to predict new non-covalent inhibitors for the SARS-CoV-2 main protease” last 15^th of May 2023 at the Faculty of Chemistry. Congratulations Guillem.

Prediction of Recurrent Mutations in SARS-CoV-2 Using Artificial Neural Networks

Wed, 30 Nov 2022 12:21:31 +0000

We show that it is possible to predict the recurrent mutations (RM) of SARS-CoV-2.

Could nucleocapsid be a next-generation COVID-19 vaccine candidate?

Wed, 30 Nov 2022 12:04:28 +0000

Saldivar-Espinoza B, Macip G, Pujadas G, Garcia-Vallve S. Could nucleocapsid be a next-generation COVID-19 vaccine candidate? Int J Infect Dis. 2022 Nov 5;125:231-232. doi: 10.1016/j.ijid.2022.11.002.

A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet?

Tue, 11 Jan 2022 09:49:35 +0000

Macip, G.; Garcia-Segura, P.; Mestres-Truyol, J.; Saldivar-Espinoza, B.; Pujadas, G.; Garcia-Vallvé, S. A Review of the Current Landscape of SARS-CoV-2 Main Protease Inhibitors: Have We Hit the Bullseye Yet? Int. J. Mol. Sci. 2022, 23, 259. https://doi.org/10.3390/ijms23010259